FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D)
PMA: P010012
·
Supplement: S570
·
Decision Oct 19, 2023
Classifications
1
FEI Numbers
26
Registration Numbers
26
Basic Information
- Device Name
- Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D)
- Trade Name
- Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT)
- PMA Number
- P010012
- Supplement Number
- S570
- Device Class
- FDA Class 3
- Product Code
- NIK
- Generic Name
- Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D)
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- October 19, 2023
- Date Received
- May 8, 2023
- Supplement Type
- Normal 180 Day Track No User Fee
- Supplement Reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Expedited Review
- N
Advisory Committee Statement
updated labeling to include information regarding the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT) Post Approval Studies [ (PAS 1) PAS for the MADIT-CRT Indicated Patient Population, Utilizing Data from the NCDR ICD Registry; (PAS 2) Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Post Approval Registry]
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| NIK | Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D) | FDA class 3 | Unknown |